Results 71 to 80 of about 334,424 (174)

Filariose linfática: doença potencialmente eliminável

Cadernos de Saúde Pública
Os resultados obtidos com o uso de esquemas terapêuticos simples, como dose única anual ou bianual de Ivermectina (IV), Dietilcarbamazina (DEC) sozinhas ou combinadas, têm sido surpreendentemente promissores na redução da infecção linfática causada pela ...
Gerusa Dreyer, Giovanini Coelho
doaj   +2 more sources

Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis

Bulletin of the World Health Organization, 2007
Fortifying salt with diethylcarbamazine (DEC) is a safe, low-cost and effective strategy to eliminate transmission of lymphatic filariasis. DEC-fortified salt has been used successfully in pilot projects in several countries and has been used ...
Patrick Lammie, Trevor Milner, Robin Houston   +2 more
doaj  

Yellapragada Subba Row: The Unsung Hero

Muller Journal of Medical Sciences and Research, 2013
A genius in more than one basic field, with many important discoveries/inventions such as folate, methotrexate, aureomycin, and diethylcarbamazine etc., The wonder drugs he created helped conquer many diseases considered incurable till then, and even ...
Priyanka Kamath, K Ashok Shenoy
doaj   +1 more source

Tropical eosinophilia: Case series on varying presentations

Journal of Family Medicine and Primary Care
Eosinophilia can be due to both infectious and non-infectious causes, many of which may be clinically indistinguishable. Filariasis, a tropical and subtropical infection, is caused by Wuchereria bancrofti, Brugia timori (B.
Goutham Krishna, Shilpa M. Manuel, V M Ananthakrishnan   +2 more
doaj   +1 more source

Tropical pulmonary eosinophilia among expatriate Indian workers in Saudi Arabia: a case series

The Egyptian Journal of Bronchology
Background Tropical pulmonary eosinophilia (TPE) is an uncommon but important manifestation of lymphatic filarial infection, caused primarily by Wuchereria bancrofti, Brugia malayi, and Brugia timori.
Salah A. M. Ali, Hasanain A. J. Gharban, Hala Alfaki, Mona Ibrahim Ahmed, Randa I. Ahmed   +4 more
doaj   +1 more source

Topoisomerase II of filarial parasite Setaria cervi: purification and characterization

Helminthologia, 2009
Reddy J., Singh A., Joshi S., Khan M., Saxena J.   +4 more
doaj   +1 more source

Coverage And Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Endemic Areas of Sagar and Damoh Districts, Madhya Pradesh

National Journal of Community Medicine, 2013
Background: Lymphatic filariasis (LF) is one of the oldest and most debilitating of the neglected tropical diseases. An estimated 120 million people in 73 endemic countries are currently infected with LF, 53 countries are implementing MDA to interrupt ...
Arvind Sharma, P K Kasar
doaj  

Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea.

PLoS Neglected Tropical Diseases
BackgroundPersons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF ...
Jannet A Tobon Ramos, Tobias Maure, Lenore Carias, Daphne Lew, Charles Goss, Anna Samuel, Livingstone Tavul, Peter U Fischer, Gary J Weil, Moses Laman, Leanne J Robinson, William Pomat, Christopher L King   +12 more
doaj   +1 more source

Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol. [PDF]

BMJ Open
Dinesh RJ, Srividya A, Jabir M, Kishanthini M, Dogra V, Tripathi B, Sharma R, Jain T, Rahi M.   +8 more
europepmc   +1 more source

First ever programmatic implementation of triple drug therapy in the prevention of lymphatic filariasis in Haiti: lessons learned in improving the quality and coverage of locally led programming in lymphatic filariasis-persistent and conflict-affected endemic communes. [PDF]

Int Health
Sommers K, Philippe WJ, Decastro GC, Jean-Baptiste M, Momprévil FN.   +4 more
europepmc   +1 more source